Pak Fah Yeow International Ltd
HKEX:239
Pak Fah Yeow International Ltd
HKEX:239
Price:
2.48
HKD
Market Closed
Market Cap:
HK$772.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Diageo PLC
LSE:DGE
|
UK |
Pak Fah Yeow International Ltd
Interest Expense
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Pak Fah Yeow International Ltd
Interest Expense Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Pak Fah Yeow International Ltd
HKEX:239
|
Interest Expense
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Regencell Bioscience Holdings Ltd
NASDAQ:RGC
|
Interest Expense
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
G
|
Grand Pharmaceutical Group Ltd
HKEX:512
|
Interest Expense
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Interest Expense
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Interest Expense
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
H
|
HUTCHMED (China) Ltd
HKEX:13
|
Interest Expense
$2.9m
|
CAGR 3-Years
64%
|
CAGR 5-Years
29%
|
CAGR 10-Years
7%
|
|
No Stocks Found
Pak Fah Yeow International Ltd
Glance View
Pak Fah Yeow International Ltd. is an investment holding company, which engages in the manufacture and sale of healthcare products under the brand name of Hoe Hin. The firm operates through three segments. Healthcare segment is engaged in the manufacture and sales of Hoe Hin products. Property Investment segment is engaged in the investment in commercial, industrial and residential properties. Treasury Investment segment is engaged in treasury investment. The firm mainly operates businesses in Hong Kong, China, Britain and Singapore, among others.
Intrinsic Value
2.38
HKD
Overvaluation 4%
